A parallel could be drawn with a study in adults suffering from ischemic stroke, where those treated with high doses of erythropoietin experienced a higher mortality rate; however, the study could not pinpoint a singular cause for this outcome [44]. The gene discussed is EPO; the disease is ischemic stroke.